SCHEMBL1084250

SCHEMBL1084250

CN(C)c1nc(-c2ccc[nH]2)nc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 12/20 0.57
▸ CYP1A2 P05177 11/20 0.57
▸ CYP3A4 P08684 9/20 0.57
▸ ALDH1A1 P00352 7/20 0.57
▸ CYP2C19 P33261 7/20 0.57
▸ TSHR P16473 6/20 0.57
▸ CYP2C9 P11712 6/20 0.57
▸ LMNA P02545 4/20 0.57
▸ GLA P06280 2/20 0.57
▸ MAPT P10636 2/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ HPGD P15428 2/20 0.57
▸ HIF1A Q16665 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ RECQL P46063 1/20 0.57
▸ CLK4 Q9HAZ1 7/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ HSD17B10 Q99714 6/20 0.52
▸ ALOX15 P16050 5/20 0.52
▸ MEN1 O00255 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1083866 0.79 CYP2D6 (0.81) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL16404334 0.79 CYP2D6 (0.87) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL26598946 0.76 METAP1 (0.51) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL23748936 0.73 TLR9 (0.66) ALDH1A1MAPK1KMT2APDE5AABCB1
SCHEMBL1083903 0.72 CYP2D6 (0.60) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL1083856 0.72 CYP2D6 (0.74) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL26639491 0.72 ALDH1A1 (0.69) ALDH1A1MAPK1KMT2AABCB1ABCG2
SCHEMBL17688811 0.72 ACP1 (0.52) ALDH1A1LMNAMAPTKDM4EHPGD
SCHEMBL937501 0.71 CYP2D6 (0.70) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL1083911 0.71 CYP2D6 (0.70) CYP2D6CYP1A2CYP3A4ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 — — US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 — — US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 — — US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 — — US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 — — US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 — — US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 — — US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 — — US disclosed
Send feedback